Medical Xpress August 5, 2024
Benjamin Y. Fong, The Conversation

An operations manager finds relief from her depression with the help of psilocybin, the primary psychoactive component of “magic mushrooms.” A veteran conquers his post-traumatic stress disorder through therapy using MDMA, a synthetic compound known on the street as “ecstasy” or “molly.” A stay-at-home mom tries LSD, otherwise known as acid, for her anxiety.

Nearly every day, such stories appear about the healing potential of .

These stories reflect a so-called “psychedelic renaissance” of the moment—a new interest in the drugs most often associated with 1960s counterculture, but now put to therapeutic rather than recreational ends.

A handful of states, spearheaded by Oregon and Colorado, are leading the way for the legalized use of various naturally occurring psychedelic compounds....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Mental Health, Patient / Consumer, Pharma, Pharma / Biotech, Provider, States
988 Mental Health Hotline Failed to Boost Service Offerings
Suicide hotline has not led to increased mental health service access: Study
Private Equity Investors Are Still Laser-Focused on Behavioral Health Care
Private Equity in Behavioral Health: Compliance Champions or Cost-Cutting Villains?
Private equity-backed company acquires New York behavioral provider

Share This Article